Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
Kitamura M, Takayama M, Matsuda J, Kubota Y, Nakamura S, Takano H, Asai K, Shimizu W. Kitamura M, et al. Among authors: matsuda j. Am J Cardiol. 2015 Sep 15;116(6):945-51. doi: 10.1016/j.amjcard.2015.06.023. Epub 2015 Jun 26. Am J Cardiol. 2015. PMID: 26209114 Free article.
Usefulness of Non-Anteroseptal Region Left Ventricular Hypertrophy Using Cardiac Magnetic Resonance to Predict Repeat Alcohol Septal Ablation for Refractory Obstructive Hypertrophic Cardiomyopathy.
Kitamura M, Amano Y, Takayama M, Shibuya J, Matsuda J, Sangen H, Nakamura S, Takano H, Asai K, Kumita S, Shimizu W. Kitamura M, et al. Among authors: matsuda j. Am J Cardiol. 2017 Jul 1;120(1):124-130. doi: 10.1016/j.amjcard.2017.03.248. Epub 2017 Apr 12. Am J Cardiol. 2017. PMID: 28483204
Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
Matsuda J, Kitamura M, Takayama M, Imori Y, Shibuya J, Kubota Y, Sangen H, Nakamura S, Takano H, Asai K, Shimizu W. Matsuda J, et al. Heart Vessels. 2018 Mar;33(3):246-254. doi: 10.1007/s00380-017-1053-9. Epub 2017 Sep 30. Heart Vessels. 2018. PMID: 28965135
Delay in seeking treatment before emergent heart failure readmission and its association with clinical phenotype.
Takei M, Harada K, Shiraishi Y, Matsuda J, Iwasaki Y, Yamamoto Y, Matsushita K, Miyazaki T, Miyamoto T, Iida K, Tanimoto S, Nagatomo Y, Hosoda T, Kohsaka S, Yamamoto T, Nagao K, Takayama M. Takei M, et al. Among authors: matsuda j. J Intensive Care. 2020 Aug 26;8:65. doi: 10.1186/s40560-020-00482-z. eCollection 2020. J Intensive Care. 2020. PMID: 32864143 Free PMC article.
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, Yodogawa K, Iwasaki YK, Yamamoto T, Takano H, Tsukada Y, Asai K, Miyamoto M, Miyauchi Y, Kodani E, Ishikawa M, Maruyama M, Ogano M, Tanabe J; EMBODY trial investigators. Shimizu W, et al. Cardiovasc Diabetol. 2020 Sep 25;19(1):148. doi: 10.1186/s12933-020-01127-z. Cardiovasc Diabetol. 2020. PMID: 32977831 Free PMC article. Clinical Trial.
Gastrointestinal bleeding increases the risk of subsequent cardiovascular events in patients with acute cardiovascular diseases requiring intensive care.
Sakai S, Tara S, Yamamoto T, Asano K, Kimura T, Fujimoto Y, Shiomura R, Matsuda J, Kadooka K, Takahashi K, Ko T, Sangen H, Saiki Y, Nakata J, Hosokawa Y, Takano H, Shimizu W. Sakai S, et al. Among authors: matsuda j. Heart Vessels. 2021 Sep;36(9):1327-1335. doi: 10.1007/s00380-021-01822-1. Epub 2021 Mar 8. Heart Vessels. 2021. PMID: 33683409 Free PMC article.
623 results